Arman Qamar: We are Routinely Evaluating VTE PRS in the Clinic in Many of Our Patients With Unprovoked VTE
Arman Qamar, Interventional Cardiologist NorthShore University HealthSystem, shared a post on LinkedIn:
“We are routinely evaluating VTE PRS in the clinic in many of our patients with unprovoked VTE. We discuss the evolving science in our recent review.”
Quoting RPTH Journal post:
“Recent studies demonstrate that polygenic risk score (PRS) significantly improves VTE risk prediction beyond traditional clinical factors. Recent findings indicate that PRS could inform thromboprophylaxis decisions for high-risk patients.”
Title: Role of polygenic risk scores in venous thromboembolism: current state and future directions
Authors: Aman Goyal, Sonia Hurjkaliani, Kevin Michael Alexander, Jianfeng Xu, Manan Pareek, Arman Qamar
Read full article here.
Stay updated with Hemostasis Today.
-
Nov 19, 2025, 18:03Andres Ricaurte Fajardo on a Strongyloides Stercoralis Hyperinfection with Thrombosis
-
Nov 19, 2025, 17:50Marilena Vrana Reflects on PPTA Europe’s Visits with Members and Stakeholders in 2025
-
Nov 19, 2025, 17:32Michael Makris Shares Insights from Global Forum Meeting of the WFH Meeting in Montreal
-
Nov 19, 2025, 17:14Yazan Abou Ismail Takes The Legacy Award from Qatar Foundation
-
Nov 19, 2025, 17:02Wolfgang Miesbach Shares Real-World Evidence on Eptacog Beta from Spain
-
Nov 19, 2025, 16:34Ishita Singh Reflects on Haematocon 2025: A Reminder of Her Commitment to The Journey
-
Nov 19, 2025, 16:23Mehdi Kashani: I’m Really Excited to Share Schistosite.com
-
Nov 19, 2025, 16:09A ”Meow-cyte” from Melaku Abay Muluneh or Why Microscopy Never Gets Old!
-
Nov 19, 2025, 15:56Cuilan Li on her Contribution to a Cutting-Edge Project in Polycythemia Vera